Citi upgrades Edwards Lifesciences Corp (NYSE: EW) from Sell to Hold. Price target increased from $42 to $50.

This article: 120 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE